BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5231700)

  • 1. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy.
    Bush IM; Whitmore WF
    J Med Soc N J; 1967 Feb; 64(2):56-60. PubMed ID: 5231700
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of tetracycline fluorescence for the early diagnosis of malignant bladder neoplasms].
    Ziehen HP; Oswald K
    Z Urol Nephrol; 1970 Jul; 63(7):523-30. PubMed ID: 5476613
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultraviolet cystoscopy in patients with bladder cancer.
    Whitmore WF; Bush IM
    Trans Am Assoc Genitourin Surg; 1965; 57():149-55. PubMed ID: 5855557
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodinamic effect and fluorescence in the diagnosis and therapy of the cancer of the bladder.
    Fedi B
    Boll Soc Ital Biol Sper; 1977 Jul; 53(14):1138-44. PubMed ID: 603661
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorescence cystoscopy: is it ready for use in routine clinical practice?
    Spiess PE; Grossman HB
    Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet cystoscopy.
    Whitmore WF; Bush IM
    JAMA; 1968 Mar; 203(12):1057-9. PubMed ID: 5694368
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescent cystoscopy in diagnosing and treating superficial cancer of the urinary bladder].
    Gorelov SI
    Urologiia; 2002; (1):25-8. PubMed ID: 11877968
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating fluorescence cystoscopy for the diagnosis of bladder cancer into clinical practice.
    Karl A; Zaak D; Stief CG
    Nat Clin Pract Urol; 2008 Aug; 5(8):424-5. PubMed ID: 18577979
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
    Witjes JA; Douglass J
    Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet light cystoscopy in patients with bladder cancer. One year's experience.
    Sorensen BL; Barlebo H; Gammelgaard PA; Soeborg Ohlsen A
    Scand J Urol Nephrol; 1969; 3(3):193-200. PubMed ID: 5375748
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
    Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
    J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The endoscopic (and intraoperative) "fluorescent screening test" in vesical and prostatic tumors].
    Fabiano A
    Acta Urol Belg; 1966 Oct; 34(4):467-82. PubMed ID: 6009528
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
    Schmidbauer J; Marberger M
    Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
    Witjes JA; Moonen PM; van der Heijden AG
    Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
    Lee CS; Yoon CY; Witjes JA
    BJU Int; 2008 Nov; 102(9 Pt B):1228-33. PubMed ID: 19035886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ALA fluorescent diagnosis of bladder cancer].
    Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
    Urologiia; 2000; (5):48-50. PubMed ID: 11392226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.